Mark R. Barvian

Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6

Peter L. Toogood, Patricia J. Harvey, Joseph T. Repine et al. · Journal of Medicinal Chemistry · 2005 · 503 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Biochemical and cellular effects of c-Src kinase-selective pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors

Alan J. Kraker, Brian G. Hartl, Aneesa M. Amar et al. · Biochemical Pharmacology · 2000 · 139 citations · Full text

Medicine, Molecular Biology, Pharmacology +12

DNA Damage Induced via 5,6-Dihydrothymid-5-yl in Single-Stranded Oligonucleotides

Marc M. Greenberg, Mark R. Barvian, Gary P. Cook et al. · Journal of the American Chemical Society · 1997 · 76 citations

Pharmacy, Biochemistry, Molecular Biology +17

Discovery and structure-activity studies of a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors

Cleo J. C. Connolly, James M. Hamby, Mel C. Schroeder et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 66 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 1: Design, synthesis and structure–activity relationship studies

Fabrice Vergne, Patrick Bernardelli, Edwige Lorthiois et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 57 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16